NHS England introduces a 10-minute Ocrelizumab injection for MS patients, replacing 4-hour infusions.
NHS England introduces a new 10-minute Ocrelizumab injection for thousands of MS patients, replacing the previous infusion method that took up to four hours. The injection is expected to save time for patients and doctors and provide a more efficient way of offering treatment. Ocrelizumab has been shown to halt symptoms of two forms of MS and is administered as a subcutaneous injection every six months.
July 12, 2024
7 Articles